哪些药品能报销一查即知

Core Points - The National Healthcare Security Administration (NHSA) has launched a new version of the basic medical insurance directory and the first commercial health insurance innovative drug directory on January 1 [1] - The updated directories were officially released in December 2025, providing users with a convenient way to check drug information through the NHSA WeChat public account [1] Group 1: New Features - Users can access the new drug directories by navigating to the "Microservices" section of the NHSA WeChat account and selecting the appropriate query options [1] - The search functionality allows users to input the generic name of a drug to determine its inclusion in the directory, classification, and reimbursement category [1] Group 2: Drug Classification - The NHSA classifies drugs in the medical insurance directory into two categories: Class A and Class B [2] - Class A drugs are essential for clinical treatment, widely used, and have proven efficacy, with full reimbursement available for insured individuals [2] - Class B drugs are also clinically effective but are priced slightly higher than Class A drugs, requiring individuals to pay a portion out-of-pocket before reimbursement [2]